$IPAR
INTERPARFUMS INC

2023 Q3 Form 10-Q Financial Statement

#000175392623001015 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $368.0M $309.2M $244.7M
YoY Change 31.2% 26.36% 17.9%
Cost Of Revenue $133.0M $120.8M $109.8M
YoY Change 34.9% 10.01% 20.15%
Gross Profit $235.0M $188.4M $134.9M
YoY Change 29.2% 39.68% 16.13%
Gross Profit Margin 63.87% 60.92% 55.12%
Selling, General & Admin $147.8M $133.4M $89.49M
YoY Change 25.87% 49.06% 25.16%
% of Gross Profit 62.89% 70.8% 66.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.400M $4.252M $3.679M
YoY Change 6.46% 15.57% 52.59%
% of Gross Profit 1.87% 2.26% 2.73%
Operating Expenses $147.8M $133.4M $89.49M
YoY Change 25.87% 49.06% 25.16%
Operating Profit $87.20M $55.02M $45.40M
YoY Change 35.25% 21.2% 1.66%
Interest Expense $2.397M $2.276M -$280.0K
YoY Change 251.47% -912.86% -65.47%
% of Operating Profit 2.75% 4.14% -0.62%
Other Income/Expense, Net -$589.0K $454.0K $328.0K
YoY Change -128.84% 38.41% -452.69%
Pretax Income $86.61M $55.48M $45.45M
YoY Change 30.21% 22.07% 3.87%
Income Tax $20.49M $12.96M $10.93M
% Of Pretax Income 23.66% 23.36% 24.04%
Net Earnings $53.21M $34.95M $27.62M
YoY Change 28.46% 26.56% 21.89%
Net Earnings / Revenue 14.46% 11.3% 11.28%
Basic Earnings Per Share $1.66 $1.09 $0.87
Diluted Earnings Per Share $1.66 $1.09 $864.3K
COMMON SHARES
Basic Shares Outstanding 31.98M shares 32.01M shares 31.85K shares
Diluted Shares Outstanding 32.12K shares 32.16K shares 31.95K shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $183.5M $186.8M $195.9M
YoY Change 3.84% -4.65% -34.23%
Cash & Equivalents $79.76M $74.31M $52.24M
Short-Term Investments $103.7M $112.4M $143.6M
Other Short-Term Assets $26.85M $24.99M $18.30M
YoY Change 39.03% 36.54% -18.27%
Inventory $364.3M $360.0M $265.8M
Prepaid Expenses
Receivables $288.1M $236.6M $192.5M
Other Receivables $13.65M $14.73M $7.664M
Total Short-Term Assets $876.9M $823.4M $680.2M
YoY Change 23.91% 21.05% 0.05%
LONG-TERM ASSETS
Property, Plant & Equipment $163.0M $168.3M $192.2M
YoY Change 6.37% -12.47% 13.65%
Goodwill
YoY Change
Intangibles $286.7M $292.3M
YoY Change 51.47%
Long-Term Investments
YoY Change
Other Assets $22.42M $25.30M $33.78M
YoY Change -1.9% -25.09% -39.28%
Total Long-Term Assets $517.5M $528.2M $422.2M
YoY Change 28.25% 25.1% -1.45%
TOTAL ASSETS
Total Short-Term Assets $876.9M $823.4M $680.2M
Total Long-Term Assets $517.5M $528.2M $422.2M
Total Assets $1.394B $1.352B $1.102B
YoY Change 25.49% 22.61% -0.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $87.16M $91.04M $83.41M
YoY Change 7.06% 9.15% 39.08%
Accrued Expenses $200.1M $194.0M $126.9M
YoY Change 50.61% 52.89% 18.08%
Deferred Revenue
YoY Change
Short-Term Debt $4.500M $4.958M $0.00
YoY Change
Long-Term Debt Due $41.77M $29.08M $13.34M
YoY Change 231.68% 117.96% -58.62%
Total Short-Term Liabilities $363.1M $341.7M $235.5M
YoY Change 46.11% 45.09% 7.93%
LONG-TERM LIABILITIES
Long-Term Debt $129.0M $138.6M $117.4M
YoY Change 19.49% 18.07% -11.93%
Other Long-Term Liabilities $25.50M $24.49M $26.59M
YoY Change 3.7% -7.91% -9.39%
Total Long-Term Liabilities $129.0M $138.6M $143.9M
YoY Change 19.49% -3.74% -11.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $363.1M $341.7M $235.5M
Total Long-Term Liabilities $129.0M $138.6M $143.9M
Total Liabilities $492.1M $480.2M $532.6M
YoY Change 38.05% -9.84% -2.63%
SHAREHOLDERS EQUITY
Retained Earnings $703.1M $669.7M
YoY Change 13.61%
Common Stock $32.00K $32.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $48.76M $48.76M
YoY Change 30.12%
Treasury Stock Shares
Shareholders Equity $690.3M $668.2M $569.8M
YoY Change
Total Liabilities & Shareholders Equity $1.394B $1.352B $1.102B
YoY Change 25.49% 22.61% -0.53%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $53.21M $34.95M $27.62M
YoY Change 28.46% 26.56% 21.89%
Depreciation, Depletion And Amortization $4.400M $4.252M $3.679M
YoY Change 6.46% 15.57% 52.59%
Cash From Operating Activities $17.50M $14.12M -$4.564M
YoY Change -13.93% -409.44% -181.62%
INVESTING ACTIVITIES
Capital Expenditures $3.200M $864.0K -$17.78M
YoY Change -163.35% -104.86% -85.11%
Acquisitions
YoY Change
Other Investing Activities $6.100M -$23.23M $1.531M
YoY Change -876.08% -1617.18% -66.29%
Cash From Investing Activities $2.900M -$24.09M -$16.25M
YoY Change -149.68% 48.28% -85.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $102.0K
YoY Change -9.73%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.10M -64.88M -38.98M
YoY Change -39.41% 66.42% -127.94%
NET CHANGE
Cash From Operating Activities 17.50M 14.12M -4.564M
Cash From Investing Activities 2.900M -24.09M -16.25M
Cash From Financing Activities -13.10M -64.88M -38.98M
Net Change In Cash 7.300M -74.84M -59.80M
YoY Change -202.48% 25.17% -297.49%
FREE CASH FLOW
Cash From Operating Activities $17.50M $14.12M -$4.564M
Capital Expenditures $3.200M $864.0K -$17.78M
Free Cash Flow $14.30M $13.26M $13.22M
YoY Change -43.67% 0.33% -89.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000822663
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
usd
CY2023Q2 us-gaap Long Term Debt Term
LongTermDebtTerm
P10Y
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
120000000
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
80000000
CY2022Q4 us-gaap Long Term Debt Term
LongTermDebtTerm
P4Y
CY2021Q2 us-gaap Long Term Debt Term
LongTermDebtTerm
P10Y
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
168264000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166722000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28005000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
55475000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
148061000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
45445000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
106668000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7M6D
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
34952000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-16469
dei Entity Registrant Name
EntityRegistrantName
INTER PARFUMS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3275609
dei Entity Address Address Line1
EntityAddressAddressLine1
551 Fifth Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10176
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
983-2640
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
dei Trading Symbol
TradingSymbol
IPAR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31975670 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74311000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104713000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
112449000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
150833000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
236554000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
197584000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
360018000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
289984000 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
14730000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
28803000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
24993000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
15650000 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
386000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
157000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
823441000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
787724000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27964000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
292319000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
290853000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14333000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11159000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25302000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24120000 usd
CY2023Q2 us-gaap Assets
Assets
1351664000 usd
CY2022Q4 us-gaap Assets
Assets
1308542000 usd
CY2023Q2 us-gaap Loans Payable To Bank
LoansPayableToBank
4958000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
29080000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28547000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5236000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5296000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
91040000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
88388000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
194036000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
213621000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
17324000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8715000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
341674000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
344567000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
138565000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
151494000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24491000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24335000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31975670 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31967300 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95984000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90186000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
669688000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
620095000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-48739000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-56056000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9949865 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9864805 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
48764000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
37475000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
668201000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
616782000 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
178733000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
171364000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
846934000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
788146000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1351664000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1308542000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309244000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
244725000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
620967000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
495403000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
120840000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90943000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
229606000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
182963000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
188404000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
153782000 usd
us-gaap Gross Profit
GrossProfit
391361000 usd
us-gaap Gross Profit
GrossProfit
312440000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
133383000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
108385000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
246061000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
205825000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
55021000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
45397000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
145300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
106615000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
2276000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
1023000 usd
us-gaap Interest Expense
InterestExpense
4633000 usd
us-gaap Interest Expense
InterestExpense
1907000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
746000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
279000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-13000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2518000 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1977000 usd
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
464000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
7359000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
-1002000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
328000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
444000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
454000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
48000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2761000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
53000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
55475000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
45445000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
148061000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
106668000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12957000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10925000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34635000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25857000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
42518000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
34520000 usd
us-gaap Profit Loss
ProfitLoss
113426000 usd
us-gaap Profit Loss
ProfitLoss
80811000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7566000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6903000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
24406000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17895000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
34952000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
27617000 usd
us-gaap Net Income Loss
NetIncomeLoss
89020000 usd
us-gaap Net Income Loss
NetIncomeLoss
62916000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.98
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32006 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31845 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32012 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31843 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32162 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31952 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32161 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31981 shares
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.625
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.30
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2023Q2 us-gaap Profit Loss
ProfitLoss
42518000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
34520000 usd
us-gaap Profit Loss
ProfitLoss
113426000 usd
us-gaap Profit Loss
ProfitLoss
80811000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
77000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
1749000 usd
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
4243000 usd
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
1488000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1709000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-992000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-454000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33630000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13035000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-46071000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
41987000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-859000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
123927000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
34244000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7566000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6903000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
24406000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17895000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-21000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-483000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-227000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-411000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
211000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
10743000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3411000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
14162000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7334000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4323000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
27590000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3322000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34653000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3464000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
96337000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30922000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
788146000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
852671000 usd
us-gaap Profit Loss
ProfitLoss
113426000 usd
us-gaap Profit Loss
ProfitLoss
80811000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
846934000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
723005000 usd
us-gaap Profit Loss
ProfitLoss
113426000 usd
us-gaap Profit Loss
ProfitLoss
80811000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
8367000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6803000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-650000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1241000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1265000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1877000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
48000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
444000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
2620000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3017000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2987000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2595000 usd
us-gaap Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions
AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions
164000 usd
us-gaap Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions
AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions
-2036000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35181000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48085000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66144000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
81188000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3406000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1872000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2579000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2822000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23425000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7916000 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
8531000 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
8869000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6765000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28508000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
97079000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2941000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
138061000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
6211000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3202000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30305000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
228000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1016000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
37552000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28051000 usd
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
4947000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15958000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7522000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5191000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
810000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
4403000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
40020000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
31844000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
20301000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
16056000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
11289000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-77430000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59015000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2711000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-578000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30402000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-116152000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104713000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168387000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74311000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52235000 usd
us-gaap Interest Paid Net
InterestPaidNet
3189000 usd
us-gaap Interest Paid Net
InterestPaidNet
1581000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
30096000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
16369000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
152000000 usd
us-gaap Acquisition Costs
AcquisitionCosts
3100000 usd
CY2023Q2 us-gaap Escrow Deposit
EscrowDeposit
1200000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
130400000 usd
us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
one-month Euribor plus 0.75%
CY2023Q2 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.02 pure
CY2023Q2 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.011 pure
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
173660000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
146772000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
186358000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
143212000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
360018000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
289984000 usd
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
54300000 usd
CY2022Q4 us-gaap Derivative Swaption Interest Rate
DerivativeSwaptionInterestRate
0.02 pure
CY2021Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
130400000 usd
CY2021Q2 us-gaap Derivative Swaption Interest Rate
DerivativeSwaptionInterestRate
0.011 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.028 pure
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1500000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2900000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1300000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3100000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2600000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2800000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2400000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
500000 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
168730 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
16.31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
23560 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
13.59
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
145170 shares
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
16.75
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
430000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
860000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
740000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1180000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
441580 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15960 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
70.48
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
93430 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
55.57
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
332190 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.44
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
187020 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
61.53
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
574935 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
21500000 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13800000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2000000.0 usd
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
5192000 usd
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
810000 usd
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
840000 usd
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
75000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5773000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
698000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
211955 shares
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
4800000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
27617000 usd
us-gaap Net Income Loss
NetIncomeLoss
89020000 usd
us-gaap Net Income Loss
NetIncomeLoss
62916000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32006 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31845 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32012 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31843 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
156 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
107 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
149 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
138 shares
CY2023Q2 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
32162 shares
CY2022Q2 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
31952 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
32161 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
31981 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.98
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309244000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
244725000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
620967000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
495403000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
34952000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
27617000 usd
us-gaap Net Income Loss
NetIncomeLoss
89020000 usd
us-gaap Net Income Loss
NetIncomeLoss
62916000 usd
CY2023Q2 us-gaap Assets
Assets
1351664000 usd
CY2022Q4 us-gaap Assets
Assets
1308542000 usd

Files In Submission

Name View Source Status
0001753926-23-001015-index-headers.html Edgar Link pending
0001753926-23-001015-index.html Edgar Link pending
0001753926-23-001015.txt Edgar Link pending
0001753926-23-001015-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g083669_10q.htm Edgar Link pending
g083669_ex31-1.htm Edgar Link pending
g083669_ex31-2.htm Edgar Link pending
g083669_ex32-1.htm Edgar Link pending
g083669_ex32-2.htm Edgar Link pending
ipar-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
ipar-20230630_cal.xml Edgar Link unprocessable
ipar-20230630_lab.xml Edgar Link unprocessable
ipar-20230630_def.xml Edgar Link unprocessable
ipar-20230630_pre.xml Edgar Link unprocessable
g083669_10q_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable